Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Dow
Boehringer Ingelheim
Medtronic
UBS
Accenture
Farmers Insurance
Merck
Federal Trade Commission

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021228

« Back to Dashboard

NDA 021228 describes DETROL LA, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from eight suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the DETROL LA profile page.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 021228
Tradename:DETROL LA
Applicant:Pharmacia And Upjohn
Ingredient:tolterodine tartrate
Patents:3
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021228
Medical Subject Heading (MeSH) Categories for 021228
Suppliers and Packaging for NDA: 021228
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 N 0009-5190-01
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 N 0009-5190-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength2MG
Approval Date:Dec 22, 2000TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Feb 26, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021228

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Dow
Merck
Accenture
Healthtrust
McKinsey
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.